Charles Wu
Board Member
Gyre Therapeutics, Inc. (GYRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-10-30–present
-
Start not stated–2024-01-15
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Gyre Therapeutics, Inc. (GYRE) | Former Chief Executive Officer | $12,500 | $15,350 |
| 2023 | Gyre Therapeutics, Inc. (GYRE) | Former Chief Executive Officer | $106,152 | $106,152 |
| 2022 | Gyre Therapeutics, Inc. (GYRE) | Chief Executive Officer | $78,347 | $78,347 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.